Annual Drug Patent Expirations for COTEMPLA+XR-ODT
Cotempla Xr-odt is a drug marketed by Neos Theraps Inc and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.
COTEMPLA XR-ODT drug price trends.
Drug patent litigation for COTEMPLA XR-ODT.
This drug has two patent family members in two countries.
The generic ingredient in COTEMPLA XR-ODT is methylphenidate. One supplier is listed for this compound. Additional details are available on the methylphenidate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
